Back to Search
Start Over
Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate.
- Source :
-
Hepatology (Baltimore, Md.) [Hepatology] 2021 Jun; Vol. 73 (6), pp. 2598-2600. Date of Electronic Publication: 2021 May 25. - Publication Year :
- 2021
- Subjects :
- Alkaline Phosphatase blood
Bilirubin blood
Chenodeoxycholic Acid administration & dosage
Chenodeoxycholic Acid adverse effects
Cholesterol blood
Dose-Response Relationship, Drug
Drug Interactions
Drug Monitoring methods
Female
Humans
Hypolipidemic Agents administration & dosage
Hypolipidemic Agents adverse effects
Liver Function Tests methods
Male
Middle Aged
Treatment Outcome
Bezafibrate administration & dosage
Bezafibrate adverse effects
Chenodeoxycholic Acid analogs & derivatives
Cholestasis diagnosis
Cholestasis drug therapy
Cholestasis etiology
Cholestasis physiopathology
Liver Cirrhosis, Biliary blood
Liver Cirrhosis, Biliary complications
Liver Cirrhosis, Biliary therapy
Pruritus chemically induced
Pruritus prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1527-3350
- Volume :
- 73
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Hepatology (Baltimore, Md.)
- Publication Type :
- Academic Journal
- Accession number :
- 33140868
- Full Text :
- https://doi.org/10.1002/hep.31613